Characterization of lassa virus cell entry inhibitors: Determination of the active enantiomer by asymmetric synthesis (original) (raw)
Virtual screening for potential inhibitors of Lassa fever nucleoprotein
Amaku James Friday, Buhari Magaji, Communication in Physical Sciences
Communication in Physical Sciences 2020, 5(3): 391-402, 2020
View PDFchevron_right
Design of a Small-Molecule Entry Inhibitor with Activity against Primary Measles Virus Strains
Richard Plemper
Antimicrobial Agents and Chemotherapy, 2005
View PDFchevron_right
Evaluation of Lassa antiviral compound ST-193 in a guinea pig model
Mark Smith
Antiviral Research, 2011
View PDFchevron_right
Identification of a Broad-Spectrum Arenavirus Entry Inhibitor
T. Bolken
Journal of Virology, 2008
View PDFchevron_right
Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion
Hector moreno
Journal of Virology, 2019
View PDFchevron_right
Development of ( E )-2-((1,4-Dimethylpiperazin-2-ylidene)amino)-5-nitro- N -phenylbenzamide, ML336: Novel 2-Amidinophenylbenzamides as Potent Inhibitors of Venezuelan Equine Encephalitis Virus
Sudeshna Roy, Julie Sotsky, Nichole Tower
Journal of Medicinal Chemistry, 2014
View PDFchevron_right
Design of peptide-based epitope vaccine and further binding site scrutiny led to groundswell in drug discovery against Lassa virus
Abu Zaffar Shibly
3 Biotech, 2018
View PDFchevron_right
Application of real-time PCR for testing antiviral compounds against Lassa virus, SARS coronavirus and Ebola virus in vitro
Beate Becker-ziaja
Antiviral Research, 2004
View PDFchevron_right
A Small-Molecule Dengue Virus Entry Inhibitor
Ma Phong
Antimicrobial Agents and Chemotherapy, 2009
View PDFchevron_right
Structure Activity Relationship Optimization of a 1,3‐Disubstituted Urea‐based Inhibitor of Zika Virus Infection
Asim Dasgupta
The FASEB Journal, 2019
View PDFchevron_right
A Host-Oriented Inhibitor of Junin Argentine Hemorrhagic Fever Virus Egress
Gordon Ruthel
Journal of Virology, 2014
View PDFchevron_right
Characterization and NMR Solution Structure of a Novel Cyclic Pentapeptide Inhibitor of Pathogenic Hantaviruses
Pamela Hall, Laurel Sillerud
Chemical Biology & Drug Design, 2007
View PDFchevron_right
Antiviral potential of some novel structural analogs of standard drugs repurposed for the treatment of COVID-19
Asim Azhar
Journal of Biomolecular Structure and Dynamics
View PDFchevron_right
Novel Small Molecule Entry Inhibitors of Ebola Virus
Arnab Basu
The Journal of infectious diseases, 2015
View PDFchevron_right
Identification of Broad-Spectrum Antiviral Compounds by Targeting Viral Entry
Mark Marsh
Viruses
View PDFchevron_right
Viral Entry Inhibitors Targeted to the Membrane Site of Action
A. Pessi
Journal of Virology, 2010
View PDFchevron_right
Nonpeptide Inhibitors of Measles Virus Entry
Weiqiang Zhan
Journal of Medicinal Chemistry, 2006
View PDFchevron_right
Inhibition of Arenaviruses by Combinations of Orally Available Approved Drugs
Jessica Oda
Antimicrobial Agents and Chemotherapy, 2021
View PDFchevron_right
Novel inhibitors targeting Venezuelan equine encephalitis virus capsid protein identified using In Silico Structure-Based-Drug- Design
sharon shechter
View PDFchevron_right
Identifying immunodominant multi-epitopes from the envelope glycoprotein of the Lassa mammarenavirus as vaccine candidate for Lassa fever
Angus Oli
Clinical and Experimental Vaccine Research
View PDFchevron_right
Identification and Mechanism of Action of a Novel Small-Molecule Inhibitor of Arenavirus Multiplication
Nhi Ngo
Journal of Virology, 2015
View PDFchevron_right
Identification of a Small-Molecule Entry Inhibitor for Filoviruses
Helena Majgier-Baranowska
Journal of Virology, 2011
View PDFchevron_right
Physical and Chemical Methods of Inactivating Lassa Virus
Graham Lloyd
The Lancet, 1982
View PDFchevron_right
Discovery of a novel compound with anti-venezuelan equine encephalitis virus activity that targets the nonstructural protein 2
Colleen Jonsson
PLoS pathogens, 2014
View PDFchevron_right
Design, synthesis, optimization and antiviral activity of a class of hybrid dengue virus E protein inhibitors
BN Sinha
Bioorganic & Medicinal Chemistry Letters, 2015
View PDFchevron_right